Lysergic acid

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 581469

CAS#: 82-58-6

Description: Lysergic acid is discontinued (DEA controlled substance). It is a precursor for a wide range of ergoline alkaloids that are produced by the ergot fungus and found in the seeds of Turbina corymbosa (ololiuhqui), Argyreia nervosa (Hawaiian baby woodrose), and Ipomoea tricolor (morning glories, tlitliltzin). Amides of lysergic acid, lysergamides, are widely used as pharmaceuticals and as psychedelic drugs (LSD). Lysergic acid received its name as it was a product of the lysis of various ergot alkaloids.

Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-10-25. Prices are subject to change without notice.

Lysergic acid is discontinued (DEA controlled substance).

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 581469
Name: Lysergic acid
CAS#: 82-58-6
Chemical Formula: C16H16N2O2
Exact Mass: 268.1212
Molecular Weight: 268.316
Elemental Analysis: C, 71.62; H, 6.01; N, 10.44; O, 11.93

Synonym: D-lysergic acid, Lysergic acid, (+)-lysergic acid, LSD

IUPAC/Chemical Name: Ergoline-8-carboxylic acid, 9,10-didehydro-6-methyl-, (8beta)-


InChi Code: InChI=1S/C16H16N2O2/c1-18-8-10(16(19)20)5-12-11-3-2-4-13-15(11)9(7-17-13)6-14(12)18/h2-5,7,10,14,17H,6,8H2,1H3,(H,19,20)/t10-,14-/m1/s1

SMILES Code: [H][C@@]1(N(C)C[C@H](C(O)=O)C=C12)CC3=CNC4=C3C2=CC=C4

Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: Halberstadt AL, Klein LM, Chatha M, Valenzuela LB, Stratford A, Wallach J, Nichols DE, Brandt SD. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology (Berl). 2018 Oct 8. doi: 10.1007/s00213-018-5055-9. [Epub ahead of print] PubMed PMID: 30298278.

2: de Coo IF, Naber WC, Wilbrink LA, Haan J, Ferrari MD, Fronczek R. Increased use of illicit drugs in a Dutch cluster headache population. Cephalalgia. 2018 Oct 5:333102418804160. doi: 10.1177/0333102418804160. [Epub ahead of print] PubMed PMID: 30290701.

3: Jalal B. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Psychopharmacology (Berl). 2018 Oct 5. doi: 10.1007/s00213-018-5042-1. [Epub ahead of print] PubMed PMID: 30288594.

4: Deco G, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris RL, Whybrow PC, Logothetis NK, Kringelbach ML. Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD. Curr Biol. 2018 Oct 8;28(19):3065-3074.e6. doi: 10.1016/j.cub.2018.07.083. Epub 2018 Sep 27. PubMed PMID: 30270185.

5: Eshleman AJ, Wolfrum KM, Reed JF, Kim SO, Johnson RA, Janowsky A. Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT(2A) receptors. Biochem Pharmacol. 2018 Sep 25;158:27-34. doi: 10.1016/j.bcp.2018.09.024. [Epub ahead of print] PubMed PMID: 30261175.

6: Bayne T, Carter O. Dimensions of consciousness and the psychedelic state. Neurosci Conscious. 2018 Sep 19;2018(1):niy008. doi: 10.1093/nc/niy008. eCollection 2018. PubMed PMID: 30254752; PubMed Central PMCID: PMC6146157.

7: Alper K, Dong B, Shah R, Sershen H, Vinod KY. LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice. Front Pharmacol. 2018 Aug 31;9:994. doi: 10.3389/fphar.2018.00994. eCollection 2018. PubMed PMID: 30233372; PubMed Central PMCID: PMC6127266.

8: Hines L, Glick J, Bilka K, Lantos JD. Medical Marijuana for Minors May Be Considered Child Abuse. Pediatrics. 2018 Oct;142(4). pii: e20174310. doi: 10.1542/peds.2017-4310. Epub 2018 Sep 13. PubMed PMID: 30213842.

9: Kaur N, Cooper WR, Duringer JM, Badillo-Vargas IE, Esparza-Díaz G, Rashed A, Horton DR. Survival and development of potato psyllid (Hemiptera: Triozidae) on Convolvulaceae: Effects of a plant-fungus symbiosis (Periglandula). PLoS One. 2018 Sep 11;13(9):e0201506. doi: 10.1371/journal.pone.0201506. eCollection 2018. PubMed PMID: 30204748; PubMed Central PMCID: PMC6133269.

10: Leonard JB, Anderson B, Klein-Schwartz W. Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016. J Psychopharmacol. 2018 Sep 5:269881118793086. doi: 10.1177/0269881118793086. [Epub ahead of print] PubMed PMID: 30182795.

11: Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol. 2018 Sep;11(9):889-902. doi: 10.1080/17512433.2018.1511424. Epub 2018 Aug 23. Review. PubMed PMID: 30102078.

12: Cameron LP, Olson DE. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT). ACS Chem Neurosci. 2018 Jul 23. doi: 10.1021/acschemneuro.8b00101. [Epub ahead of print] PubMed PMID: 30036036.

13: Lo D, Cobbs L, Chua M, Young J, Haberman ID, Modi Y. "Eye Dropping"-A Case Report of Transconjunctival Lysergic Acid Diethylamide Drug Abuse. Cornea. 2018 Oct;37(10):1324-1325. doi: 10.1097/ICO.0000000000001692. PubMed PMID: 30004961.

14: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from PubMed PMID: 30000401.

15: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from PubMed PMID: 30000391.

16: Dunlap LE, Andrews AM, Olson DE. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine. ACS Chem Neurosci. 2018 Jul 12. doi: 10.1021/acschemneuro.8b00155. [Epub ahead of print] PubMed PMID: 30001118.

17: Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC. Psychedelics and Personality. ACS Chem Neurosci. 2018 Jun 4. doi: 10.1021/acschemneuro.8b00237. [Epub ahead of print] PubMed PMID: 29863323.

18: Murty LD, Duringer JM, Craig AM. Co-exposure of the Mycotoxins Lolitrem B and Ergovaline in Steers Fed Perennial Ryegrass ( Lolium perenne) Straw: Metabolic Characterization of Excreta. J Agric Food Chem. 2018 Jun 27;66(25):6394-6401. doi: 10.1021/acs.jafc.8b00963. Epub 2018 Jun 14. PubMed PMID: 29847929.

19: Thiessen MS, Walsh Z, Bird BM, Lafrance A. Psychedelic use and intimate partner violence: The role of emotion regulation. J Psychopharmacol. 2018 Jul;32(7):749-755. doi: 10.1177/0269881118771782. Epub 2018 May 29. PubMed PMID: 29807492.

20: Lipari RN, Williams MR, Copello EAP, Pemberton MR. Risk and Protective Factors and Estimates of Substance Use Initiation: Results from the 2015 National Survey on Drug Use and Health. CBHSQ Data Review. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2012-. PubMed PMID: 29792622.